BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18053454)

  • 1. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
    Iwanaga M; Tagawa M; Tsukasaki K; Kamihira S; Tomonaga M
    Mayo Clin Proc; 2007 Dec; 82(12):1474-9. PubMed ID: 18053454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.
    Iwanaga M; Tagawa M; Tsukasaki K; Matsuo T; Yokota K; Miyazaki Y; Fukushima T; Hata T; Imaizumi Y; Imanishi D; Taguchi J; Momita S; Kamihira S; Tomonaga M
    Blood; 2009 Feb; 113(8):1639-50. PubMed ID: 18849487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
    N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
    Fujimura K; Sugiyama A; Akita T; Ohisa M; Nagashima S; Katayama K; Maeda R; Tanaka J
    Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of monoclonal gammopathy in Morocco - A hospital-based study.
    Ouzzif Z; Doghmi K; Messaoudi N; Bouhsain S; El Machtani S; Biaz A; Rachid A; Dami A; Bezza A; El Maataoui A
    Cancer Rep (Hoboken); 2023 May; 6(5):e1814. PubMed ID: 36999311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
    Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
    Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathies of undetermined significance: a review.
    Kyle RA; Rajkumar SV
    Immunol Rev; 2003 Aug; 194():112-39. PubMed ID: 12846812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
    Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
    Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
    Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
    Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of monoclonal gammopathy of undetermined significance in Thailand.
    Watanaboonyongcharoen P; Nakorn TN; Rojnuckarin P; Lawasut P; Intragumtornchai T
    Int J Hematol; 2012 Feb; 95(2):176-81. PubMed ID: 22234527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
    Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
    J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.